MetLife Files 8-K on Common and Preferred Stock

TL;DR

MetLife filed an 8-K on 12/22/25 updating stock info. Nothing major to see here.

AI Summary

MetLife, Inc. filed an 8-K on December 22, 2025, reporting information related to its common and preferred stock (Series A, E, and F). The filing indicates no significant changes or events requiring immediate disclosure beyond routine reporting as of the report date.

Why It Matters

This filing provides an update on MetLife's capital structure, specifically regarding its common and preferred stock, which is important for investors tracking the company's financial standing.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report with no indication of material adverse events or significant financial changes.

Key Numbers

• 1-15787 — SEC File Number (Identifies MetLife's filing with the SEC.)
• 13-4075851 — IRS Employer Identification No. (MetLife's tax identification number.)

Key Players & Entities

• METLIFE, INC. (company) — Registrant
• Delaware (jurisdiction) — State of Incorporation
• 200 Park Avenue, New York, NY 10166-0188 (address) — Principal Executive Offices
• December 22, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $0.01 M — ich registered Common Stock, par value $0.01 MET New York Stock Exchange Floating Rat
• $385 million — investment income will be approximately $385 million to $435 million (pre-tax), relative to
• $435 million — e will be approximately $385 million to $435 million (pre-tax), relative to its quarterly ta
• $425 million — x), relative to its quarterly target of $425 million (pre-tax) (based on full-year 2025 guid
• $1.7 billion — ull-year 2025 guidance of approximately $1.7 billion (pre-tax)). Variable investment income
• $1.6 billion — ty portfolio, which would contribute to $1.6 billion (pre-tax) of total estimated variable i
• $4 billion — portunities, with an estimated total of $4 billion deployed in 2025, and an additional app
• $1 billion — n 2025, and an additional approximately $1 billion in 2025 to support merger and acquisiti
• $2.85 b — stock repurchases will be approximately $2.85 billion, including approximately $430 mil
• $430 million — $2.85 billion, including approximately $430 million in the quarter ending December 31, 2025

Filing Documents

• met-20251222.htm (8-K) — 34KB
• 0001099219-25-000239.txt ( ) — 198KB
• met-20251222.xsd (EX-101.SCH) — 2KB
• met-20251222_def.xml (EX-101.DEF) — 16KB
• met-20251222_lab.xml (EX-101.LAB) — 29KB
• met-20251222_pre.xml (EX-101.PRE) — 17KB
• met-20251222_htm.xml (XML) — 6KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. MetLife, Inc. (the "Company") is furnishing this Current Report on Form 8-K to disclose certain preliminary results and outlook information prior to the availability of the Company's quarterly earnings release, quarterly financial supplement and outlook materials for the quarter and full year ending December 31, 2025, scheduled for release on February 4, 2026. Variable Investment Income Based on preliminary results received to date, for the quarter ending December 31, 2025, the Company estimates that its variable investment income will be approximately $385 million to $435 million (pre-tax), relative to its quarterly target of $425 million (pre-tax) (based on full-year 2025 guidance of approximately $1.7 billion (pre-tax)). Variable investment income includes private equity, real estate and other funds and prepayment fees. Based on preliminary results received to date, for full year 2025, the Company anticipates a return on its private equity investment portfolio of approximately 7.7%. Additionally, for its outlook in 2026, the Company will incorporate an assumed 9% annual return on its private equity portfolio, which would contribute to $1.6 billion (pre-tax) of total estimated variable investment income for full year 2026. Further, the Company anticipates variable investment income asset balances will decrease over the near term (one to three years). Capital Management The Company's first priority for capital deployment is to support organic growth opportunities, with an estimated total of $4 billion deployed in 2025, and an additional approximately $1 billion in 2025 to support merger and acquisition activity, including funding for the expected closing of the Company's previously announced acquisition of PineBridge Investments. For the full year 2025, the Company expects its total common stock repurchases will be approximately $2.85 billion, including approximately $430 million in the quarter ending December 31, 2025. The

Forward-Looking Statements and Other Information

Forward-Looking Statements and Other Information The preliminary financial information presented above for the quarter and full year ending December 31, 2025, is estimated and unaudited and has been prepared in good faith on a basis consistent with prior periods based on information available to management as of the date hereof; however, we have not completed our financial closing procedures for the quarter ending December 31, 2025, and our actual results could be materially different from these preliminary financial results. As a result, prospective investors should exercise caution in relying on this information and should not draw any inferences from this information regarding financial or operating data not provided. These preliminary financial results should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP. In addition, these preliminary financial results are not necessarily indicative of the results to be achieved in any future period. The Company's outlook relies on the accuracy of its assumptions about future economic and business conditions, which can be affected by known and unknown risks, uncertainties and other factors. The Company continually reviews its assumptions, implements mitigation plans, and takes precautions. The Company may revise its outlook as it obtains more information regarding economic conditions, regulatory changes, and other events, and the impact of these events on its business operations, investment portfolio, derivatives, financial results and financial condition. The forward-looking statements in this disclosure, which use terms such as "anticipates," "assumptions," "estimates," "expects," "guidance," "outlook," "preliminary," "target" and "will," are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife, Inc.'s results could differ materially f

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. METLIFE, INC. By: /s/ Adrienne O'Neill Name: Adrienne O'Neill Title: Executive Vice President and Chief Accounting Officer Date: December 22, 2025 3

View Full Filing

View this 8-K filing on SEC EDGAR